Clarivate Annual G20 Scorecard Examines Global Research and Innovation Trends Across G20 Members
Dynamic, interactive data visualizations reveal comprehensive view of the global research and innovation landscape
The scorecard is designed for the responsible evaluation of the research and innovation capabilities of the
Emmanuel Thiveaud, Senior Vice President for Research & Analytics, Academia & Government at Clarivate said: "We promote responsible research assessment by considering comprehensive profiles and indicators that capture the broad contributions research makes to society in terms of quality and impact."
"The
Key findings in the 2024
-
The
African Union (AU) shows a high collaboration rate, collaborations with Mainland China yield higher citation impact than those with theU.S. , their leading partner. The AU's SDG priorities are No Poverty (SDG 1) and Gender Equality (SDG 5). -
The
European Union is the largest contributor of papers than any otherG20 member. 40% of collaboration is with external partners compared to 10% within the EU. It publishes more open access papers than theG20 average. - Germany has a high number of researchers per capita. It exhibits above world average Category Normalized Citation Impact™ (CNCI) for collaborative papers and its Normalized Patent Citation Impact* is around twice the world average in Medicine. More than 60% of papers produced in 2023 were open access.
-
India has seen international collaboration increase to just over one-third (35.6%) over the decade (2014 to 2023), theU.S. is its leading collaborator. Its SDG focus on Economic Growth (SDG 8) and Industry (SDG 9) are the most impactful. -
Mainland
China's international collaborations are mostly bilateral (around three quarters). Its most frequent partner remains theU.S. , although the percentage has halved over the decade (2014 – 2023) from 12% to 6%. Its Normalized Patent Citation Impact is above world average. -
South Korea's collaborations with theU.S. have fallen, while those with Mainland China andIndia are rising. It also shows high Normalized Patent Citation Impact inGood Health (SDG 3) and Sustainable Cities (SDG 11), at around 1.6 and 1.4 times the world average respectively. -
United Kingdom's research output has a high citation impact with CNCI at 1.4 times world average; Collaboration rose from below 60% in 2015 to over 70% since 2022, with leading partners in theU.S. ,Germany and increasingly, Mainland China. Its Normalized Patent Citation Impact is strong in Engineering and Technology, Medicine and Life Sciences. -
United States exhibits high Normalized Patent Citation Impact in Engineering and Technology, Life Sciences and Medicine. On the UN SDGs, there is a strong focus on Peace & Justice (SDG 16) and Reduced Inequalities (SDG 10) in terms of paper output and a strong focus onGood Health (SDG 3) and Clean Energy (SDG 7) in terms of citation impact from patents.
Notes to editors:
The
The members of the
* Mainland China includes data from Hong Kong SAR and Macau SAR
*The Normalized Patent Citation Impact™ measures the number of citations each paper receives from related patents; the total is normalized against the average number of citations received by all papers published in the same year.
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com
Media contact:
newsroom@clarivate.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-annual-g20-scorecard-examines-global-research-and-innovation-trends-across-g20-members-302196953.html
SOURCE